Ancestry of the Brazilian TP53 c.1010G>A (p.Arg337His, R337H) Founder Mutation: Clues from Haplotyping of Short Tandem Repeats on Chromosome 17p

Rare germline mutations in TP53 (17p13.1) cause a highly penetrant predisposition to a specific spectrum of early cancers, defining the Li-Fraumeni Syndrome (LFS). A germline mutation at codon 337 (p.Arg337His, c1010G>A) is found in about 0.3% of the population of Southern Brazil. This mutation is associated with partially penetrant LFS traits and is found in the germline of patients with early cancers of the LFS spectrum unselected for familial history. To characterize the extended haplotypes carrying the mutation, we have genotyped 9 short tandem repeats on chromosome 17p in 12 trios of Brazilian p.Arg337His carriers. Results confirm that all share a common ancestor haplotype of Caucasian/Portuguese-Iberic origin, distant in about 72–84 generations (2000 years assuming a 25 years intergenerational distance) and thus pre-dating European migration to Brazil. So far, the founder p.Arg337His haplotype has not been detected outside Brazil, with the exception of two residents of Portugal, one of them of Brazilian origin. On the other hand, increased meiotic recombination in p.Arg337His carriers may account for higher than expected haplotype diversity. Further studies comparing haplotypes in populations of Brazil and of other areas of Portuguese migration are needed to understand the historical context of this mutation in Brazil.

[1]  Chang S. Chan,et al.  Whole-genome sequencing analysis of phenotypic heterogeneity and anticipation in Li–Fraumeni cancer predisposition syndrome , 2014, Proceedings of the National Academy of Sciences.

[2]  P. Hainaut,et al.  Prevalence of the TP53 p.R337H Mutation in Breast Cancer Patients in Brazil , 2014, PloS one.

[3]  P. Ashton-Prolla,et al.  Mutation spectrum in South American Lynch syndrome families , 2013, Hereditary cancer in clinical practice.

[4]  P. Hainaut,et al.  Li‐Fraumeni and Li‐Fraumeni—like syndrome among children diagnosed with pediatric cancer in Southern Brazil , 2013, Cancer.

[5]  R. Reis,et al.  Optimization of a pentaplex panel for MSI analysis without control DNA in a Brazilian population: correlation with ancestry markers , 2013, European Journal of Human Genetics.

[6]  R. Reis,et al.  The Impact of Polymorphic Variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the Risk and Prognosis of Portuguese Patients with Non-Small Cell Lung Cancer , 2013, PloS one.

[7]  S. Farrington,et al.  The MSH2 c.388_389del mutation shows a founder effect in Portuguese Lynch syndrome families , 2013, Clinical genetics.

[8]  E. Lalli,et al.  Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  P. Hainaut,et al.  A TP53 founder mutation, p.R337H, is associated with phyllodes breast tumors in Brazil , 2013, Virchows Archiv.

[10]  P. Hainaut,et al.  TP53 p.R337H is a conditional cancer-predisposing mutation: further evidence from a homozygous patient , 2013, BMC Cancer.

[11]  B. Figueiredo,et al.  Molecular epidemiology of adrenocortical tumors in southern Brazil , 2012, Molecular and Cellular Endocrinology.

[12]  M. Fassnacht,et al.  TP53 germline mutations in adult patients with adrenocortical carcinoma. , 2012, The Journal of clinical endocrinology and metabolism.

[13]  M. King,et al.  International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation , 2011, Breast Cancer Research and Treatment.

[14]  J. A. Yunes,et al.  Association of the highly prevalent TP53 R337H mutation with pediatric choroid plexus carcinoma and osteosarcoma in Southeast Brazil , 2011, Cancer.

[15]  E. Lalli,et al.  Increased Incidence of Choroid Plexus Carcinoma Due to the Germline TP53 R337H Mutation in Southern Brazil , 2011, PloS one.

[16]  M. Hutz,et al.  The Genomic Ancestry of Individuals from Different Geographical Regions of Brazil Is More Uniform Than Expected , 2011, PloS one.

[17]  L. Excoffier,et al.  Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows , 2010, Molecular ecology resources.

[18]  A. Amorim,et al.  Assessing individual interethnic admixture and population substructure using a 48–insertion‐deletion (INSEL) ancestry‐informative marker (AIM) panel , 2010, Human mutation.

[19]  M. Olivier,et al.  Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect , 2010, Human mutation.

[20]  R. Hofstra,et al.  TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset , 2009, Familial Cancer.

[21]  S. Shurtleff,et al.  Association of the germline TP53 R337H mutation with breast cancer in southern Brazil , 2008, BMC Cancer.

[22]  C. Bonaïti‐pellié,et al.  Molecular basis of the Li–Fraumeni syndrome: an update from the French LFS families , 2008, Journal of Medical Genetics.

[23]  M. Olivier,et al.  Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil. , 2008, Cancer letters.

[24]  M. Olivier,et al.  Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database , 2007, Human mutation.

[25]  R. Reis,et al.  Association between Functional EGF+61 Polymorphism and Glioma Risk , 2007, Clinical Cancer Research.

[26]  M. Olivier,et al.  The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. , 2007, Cancer letters.

[27]  M. Bortolini,et al.  mtDNA Haplogroup Analysis of Black Brazilian and Sub-Saharan Populations: Implications for the Atlantic Slave Trade , 2006, Human biology.

[28]  Pawel Stankiewicz,et al.  Genomic Disorders: Molecular Mechanisms for Rearrangements and Conveyed Phenotypes , 2005, PLoS genetics.

[29]  P. Donnelly,et al.  A Fine-Scale Map of Recombination Rates and Hotspots Across the Human Genome , 2005, Science.

[30]  A. Al-Chalabi,et al.  A common founder for amyotrophic lateral sclerosis type 8 (ALS8) in the Brazilian population , 2005, Human Genetics.

[31]  P. Boffetta,et al.  Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation , 2005, Journal of Medical Genetics.

[32]  E. Génin,et al.  Estimating the age of rare disease mutations: the example of Triple-A syndrome , 2004, Journal of Medical Genetics.

[33]  A. Damasceno,et al.  Contribution for an African autosomic STR database (AmpF/STR Identifiler and Powerplex 16 System) and a report on genotypic variations. , 2004, Forensic science international.

[34]  Bruce Rannala,et al.  DMLE+: Bayesian linkage disequilibrium gene mapping , 2002, Bioinform..

[35]  Í. Lopes-Cendes,et al.  Ancestral origins of the Machado-Joseph disease mutation: a worldwide haplotype study. , 2001, American journal of human genetics.

[36]  C. Bonaïti‐pellié,et al.  Sensitivity and predictive value of criteria for p53germline mutation screening , 2001, Journal of medical genetics.

[37]  M. Zago,et al.  Multiple founder haplotypes of mitochondrial DNA in Amerindians revealed by RFLP and sequencing , 1996, Annals of human genetics.

[38]  Y. Agid,et al.  Linkage disequilibrium at the Machado-Joseph disease/spinal cerebellar ataxia 3 locus: evidence for a common founder effect in French and Portuguese-Brazilian families as well as a second ancestral Portuguese-Azorean mutation. , 1995, American journal of human genetics.

[39]  L. Strong,et al.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.

[40]  W. Blattner,et al.  A cancer family syndrome in twenty-four kindreds. , 1988, Cancer research.

[41]  M. S. Levy.  [The role of international migration on the evolution of the Brazilian population (1872 to 1972)]. , 1974, Revista de saude publica.

[42]  J. Fraumeni,et al.  Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. , 1969 .

[43]  Magali Olivier,et al.  TP53 mutations in human cancers: origins, consequences, and clinical use. , 2010, Cold Spring Harbor perspectives in biology.

[44]  M. Olivier,et al.  TP 53 Mutations in Human Cancers : Origins , Consequences , and Clinical Use , 2009 .

[45]  W. Mcdougal.  An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. , 2002, The Journal of urology.